Organigram receives license to increase capacity to 16,000 kg/year
New Brunswick-based Organigram Holdings Inc. (TSX:OGI) (OTC:OGRMF), a leading Canadian producer of medical cannabis, received an expanded cultivation license for its Phase 2 expansion. The license covers the expanded 3.4 acre facility, and the first ten of Organigram’s new 23 three-level cultivation rooms.
The company will begin harvests from these new rooms in April. The remaining 13 rooms will come on line in March. With the company’s three-level canopy growing system, the 23 cultivation rooms will increase their capacity from 5,200 kg/year to roughly 16,000 kg/year.
“We’ve spent years perfecting three-level growing technology, said Greg Engel. “We have developed a world-class cannabis production facility and (will) offer our medical and adult recreational customers exceptional award winning…product in 2018 and beyond.”
The Phase 3 expansion to be completed in May 2018 will increase production to 25,000 kg/annum. A fully-funded Phase 4 expansion scheduled to start construction in April will bring capacity to 65,000 kg/annum in three stages over the next two years.
The Phase 2 expansion also includes a fully automated irrigation system, automated potting, fully automated waste destruction system and automated packaging lines for cost savings and increased yields.
Organigram receives license to increase capacity to 16,000 kg/year
About Cannin: Your Cannabis Stocks Resource
Cannin is your #1 trusted resource for cannabis stocks. Our global team of experts evaluates all emerging cannabis stock investing opportunities. We aggregate hundreds of hours of financial research and provide tips on the best cannabis stocks for 2020.
Use Cannin as your resource for:
- Cannabis and hemp investing news
- Featured cannabis and hemp company analysis
- Comprehensive cannabis and hemp stock reports
Market analysts expect the marijuana and hemp industry will have an annual value exceeding $75 Billion in the next decade. Is it too late to invest in marijuana stocks? No! This is the perfect time to invest.
Are you looking to buy stock in hemp companies or marijuana companies for 2020? Interested in new penny hemp stock companies? Looking for the best Canadian cannabis stocks to invest in? Looking to leverage the power of algorithmic stock trading to beat the cannabis market? We can help.
Are you interested in cannabis stocks like Curaleaf, Trulieve, Aurora Cannabis, Charlotte’s Web, Canopy Growth, or Hemp Inc.?
Predict price movements of cannabis stocks several hours in advance with our proprietary algorithmic stock trading software.
- +25% Gains in 2020
- +49.8% Gains in 2019
- Backtested since 2012
We’re so confident you’ll love our algotrading cannabis stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.
Profit from the best cannabis stocks – we’ll show you how at cannin.com.
Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading, Investing in Hemp Stocks